490 related articles for article (PubMed ID: 32603820)
1. The role of CREB and BDNF in neurobiology and treatment of Alzheimer's disease.
Amidfar M; de Oliveira J; Kucharska E; Budni J; Kim YK
Life Sci; 2020 Sep; 257():118020. PubMed ID: 32603820
[TBL] [Abstract][Full Text] [Related]
2. CBP gene transfer increases BDNF levels and ameliorates learning and memory deficits in a mouse model of Alzheimer's disease.
Caccamo A; Maldonado MA; Bokov AF; Majumder S; Oddo S
Proc Natl Acad Sci U S A; 2010 Dec; 107(52):22687-92. PubMed ID: 21149712
[TBL] [Abstract][Full Text] [Related]
3. Angelica tenuissima Nakai Ameliorates Cognitive Impairment and Promotes Neurogenesis in Mouse Model of Alzheimer's Disease.
Choi M; Lee Y; Cho SH
Chin J Integr Med; 2018 May; 24(5):378-384. PubMed ID: 28578486
[TBL] [Abstract][Full Text] [Related]
4. SCM-198 Ameliorates Cognitive Deficits, Promotes Neuronal Survival and Enhances CREB/BDNF/TrkB Signaling without Affecting Aβ Burden in AβPP/PS1 Mice.
Hong ZY; Yu SS; Wang ZJ; Zhu YZ
Int J Mol Sci; 2015 Aug; 16(8):18544-63. PubMed ID: 26262618
[TBL] [Abstract][Full Text] [Related]
5. Improvement of spatial memory function in APPswe/PS1dE9 mice after chronic inhibition of phosphodiesterase type 4D.
Sierksma AS; van den Hove DL; Pfau F; Philippens M; Bruno O; Fedele E; Ricciarelli R; Steinbusch HW; Vanmierlo T; Prickaerts J
Neuropharmacology; 2014 Feb; 77():120-30. PubMed ID: 24067928
[TBL] [Abstract][Full Text] [Related]
6. CREB signals as PBMC-based biomarkers of cognitive dysfunction: A novel perspective of the brain-immune axis.
Bartolotti N; Lazarov O
Brain Behav Immun; 2019 May; 78():9-20. PubMed ID: 30641141
[TBL] [Abstract][Full Text] [Related]
7. Oligomeric amyloid decreases basal levels of brain-derived neurotrophic factor (BDNF) mRNA via specific downregulation of BDNF transcripts IV and V in differentiated human neuroblastoma cells.
Garzon DJ; Fahnestock M
J Neurosci; 2007 Mar; 27(10):2628-35. PubMed ID: 17344400
[TBL] [Abstract][Full Text] [Related]
8. Farnesoid X Receptor (FXR) Aggravates Amyloid-β-Triggered Apoptosis by Modulating the cAMP-Response Element-Binding Protein (CREB)/Brain-Derived Neurotrophic Factor (BDNF) Pathway In Vitro.
Chen Q; Ma H; Guo X; Liu J; Gui T; Gai Z
Med Sci Monit; 2019 Dec; 25():9335-9345. PubMed ID: 31812977
[TBL] [Abstract][Full Text] [Related]
9. Cyclic AMP response element-binding protein (CREB) phosphorylation: a mechanistic marker in the development of memory enhancing Alzheimer's disease therapeutics.
Scott Bitner R
Biochem Pharmacol; 2012 Mar; 83(6):705-14. PubMed ID: 22119240
[TBL] [Abstract][Full Text] [Related]
10. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.
Shin MK; Kim HG; Baek SH; Jung WR; Park DI; Park JS; Jo DG; Kim KL
Neurobiol Aging; 2014 May; 35(5):990-1001. PubMed ID: 24268884
[TBL] [Abstract][Full Text] [Related]
11. TrkB reduction exacerbates Alzheimer's disease-like signaling aberrations and memory deficits without affecting β-amyloidosis in 5XFAD mice.
Devi L; Ohno M
Transl Psychiatry; 2015 May; 5(5):e562. PubMed ID: 25942043
[TBL] [Abstract][Full Text] [Related]
12. CREB expression mediates amyloid β-induced basal BDNF downregulation.
Rosa E; Fahnestock M
Neurobiol Aging; 2015 Aug; 36(8):2406-13. PubMed ID: 26025137
[TBL] [Abstract][Full Text] [Related]
13. Chenodeoxycholic Acid Ameliorates AlCl
Bazzari FH; Abdallah DM; El-Abhar HS
Molecules; 2019 May; 24(10):. PubMed ID: 31137621
[TBL] [Abstract][Full Text] [Related]
14. Roflumilast ameliorates cognitive impairment in APP/PS1 mice via cAMP/CREB/BDNF signaling and anti-neuroinflammatory effects.
Feng H; Wang C; He W; Wu X; Li S; Zeng Z; Wei M; He B
Metab Brain Dis; 2019 Apr; 34(2):583-591. PubMed ID: 30610438
[TBL] [Abstract][Full Text] [Related]
15. Anti-depressant natural flavonols modulate BDNF and beta amyloid in neurons and hippocampus of double TgAD mice.
Hou Y; Aboukhatwa MA; Lei DL; Manaye K; Khan I; Luo Y
Neuropharmacology; 2010 May; 58(6):911-20. PubMed ID: 19917299
[TBL] [Abstract][Full Text] [Related]
16. IVIG immunotherapy protects against synaptic dysfunction in Alzheimer's disease through complement anaphylatoxin C5a-mediated AMPA-CREB-C/EBP signaling pathway.
Gong B; Pan Y; Zhao W; Knable L; Vempati P; Begum S; Ho L; Wang J; Yemul S; Barnum S; Bilski A; Gong BY; Pasinetti GM
Mol Immunol; 2013 Dec; 56(4):619-29. PubMed ID: 23911420
[TBL] [Abstract][Full Text] [Related]
17. Beta -amyloid-(1-42) impairs activity-dependent cAMP-response element-binding protein signaling in neurons at concentrations in which cell survival Is not compromised.
Tong L; Thornton PL; Balazs R; Cotman CW
J Biol Chem; 2001 May; 276(20):17301-6. PubMed ID: 11278679
[TBL] [Abstract][Full Text] [Related]
18. Beta-amyloid peptide at sublethal concentrations downregulates brain-derived neurotrophic factor functions in cultured cortical neurons.
Tong L; Balazs R; Thornton PL; Cotman CW
J Neurosci; 2004 Jul; 24(30):6799-809. PubMed ID: 15282285
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective effects of carbenoxolone against amyloid-beta 1-42 oligomer-induced neuroinflammation and cognitive decline in rats.
Sharma S; Saini A; Nehru B
Neurotoxicology; 2021 Mar; 83():89-105. PubMed ID: 33412218
[TBL] [Abstract][Full Text] [Related]
20. Propranolol reduces cognitive deficits, amyloid and tau pathology in Alzheimer's transgenic mice.
Dobarro M; Gerenu G; Ramírez MJ
Int J Neuropsychopharmacol; 2013 Nov; 16(10):2245-57. PubMed ID: 23768694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
